June 7, 2018 | Written by: Watson Health
Categorized: Blog Post | Life Sciences
Share this post:
“We’re all patients,” noted Dr. Michelle McMurry-Heath, a panelist in the first plenary session that kicked off ISPOR 2018, a 5-day conference devoted to health economics and outcomes research (HEOR) in Baltimore at the end of May. In saying so, the Vice President of Regulatory Affairs for Johnson & Johnson voiced the immediacy of the research that was highlighted in this year’s presentations, health research that affects every one of us.
“Patients,” she went on to say, “are making decisions and preferences every day.” One of her co-panelists agreed that “most people’s lives happen outside of the hospital, outside of the doctor’s office.” And in a spotlight session that followed, Dr. Harlan Krumholz of Yale University stressed that “medicine is now an information science and will be unrecognizable in 10 years.”
This feeling was echoed throughout ISPOR where many sessions were devoted to areas in digital health and AI and trends exceptionally aligned with offerings from IBM Watson Health:
• accelerating drug approvals
• decreasing drug spending
• delivering innovative and curative therapies
• serving an aging population
• developing preventive medicine
As speaker Dr. Adrian Hernandez from Duke University aptly concluded, “To lock up the data is to lock up the answers.” At Watson Health, we’re all about revealing answers, and we’re eager to share how our solutions in the life sciences are enabling streamlined approaches to both discovery and speed-to-market.
Meet us at our next event, DIA 2018